Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar details
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Research interviews
-
1. The regulation of cell therapy- Prof. Moutih Rafei
-
17 min
2. How and why neurons die in Alzheimer's disease?- Prof. Bart De Strooper
-
11 min
3. The future of blood tests in cancer treatment- Dr. Isaac Garcia-Murillas
-
4. Role of marketing authorization holder in drug safety- Dr. Raphael Elmadjian Pareschi
-
25 min
5. Synthetic whole embryo models and their applications- Prof. Jacob (Yaqub) Hanna
-
31 min
6. Scale-up challenges in the production of nanomedicines from lab to industry- Prof. Dr. Oya Tagit
-
14 min
7. Artificial intelligence in precision medicine- Dr. Michael P. Menden
-
30 min
8. Translational medicine: the risk of failure in delay and how to reduce it- Prof. Martin Wehling
-
8 min
9. Challenges and solutions of scaling up- Dr. Shaukat Ali
-
15 min
-
31 min
11. Management of generic drug development: challenges and opportunities- Mr. Sandeep Patil
-
10 min
12. MassBank development and future- Dr. Emma L. Schymanski
-
31 min
13. Elite controllers of HIV: from discovery to future therapies- Prof. Bruce Walker
-
25 min
14. Translational research in amyotrophic lateral sclerosis (ALS)- Prof. Aaron D. Gitler
-
10 min
-
25 min
16. PANDAS: a potential link between group A streptococcal infections and neurological disorders- Prof. P. Patrick Cleary
-
29 min
17. Rheumatic diseases and musculoskeletal pain- Prof. Anisur Rahman
-
23 min
18. Towards developing a universal influenza vaccine- Prof. Peter Palese
- Clinical interviews
-
21 min
19. Monkeypox: etiopathogenesis, prevention, and treatments- Dr. Dennis Hruby
-
13 min
20. Kidney xenotransplantation- Dr. Douglas J. Anderson
-
28 min
21. CAR-T and TCR-T cellular immunotherapies in oncology- Prof. Sebastian Kobold
-
28 min
22. MAPS: the business of medical affairs- Dr. Danie du Plessis
-
26 min
23. Hypertrophic cardiomyopathy: therapies and treatments- Prof. Srihari Naidu
-
24 min
24. Combating the HIV epidemic- Prof. William Blattner
-
17 min
25. Epigenetic pharmaceuticals used in the clinic- Dr. Thomas Paul
-
21 min
26. Precision cancer medicine: development and future- Prof. Maurie Markman
-
31 min
27. Pediatric cancer testing- Prof. Joshua Schiffman
-
27 min
28. Opposition to vaccination: a transatlantic discussion- Prof. Jonathan Temte
-
26 min
29. Elective caesarean sections from an evolutionary perspective- Prof. Wenda Trevathan
-
19 min
30. Antiphospholipid syndrome and Lupus- Prof. Graham Hughes
-
16 min
31. Prescribing medications to children - a GP’s view- Dr. Amanda Simmons
Topics Covered
- The discovery of HIV and elite controllers
- Initial research and clinical trials
- From HIV elite controllers to an HIV vaccine
- HIV structural constraints, structurally important regions and viral fitness
- Current and future challenges in HIV treatments
Biography
Bruce D. Walker, M.D. is the Phillip T. and Susan M. Ragon Professor of Immunology and Medicine at Harvard Medical School, Professor of Microbiology and Immunobiology at Harvard T.H. Chan School of Public Health, and a Howard Hughes Medical Institute (HHMI) Investigator. He is the founding and current director of the Ragon Institute of MGH, MIT and Harvard, whose mission is to create cross-disciplinary collaborations in order to harness the immune system to prevent and cure human disease. In addition to his clinical duties as an Infectious Disease specialist at Massachusetts General Hospital, his research focuses on cellular immune responses in chronic human viral infections, with a particular focus on HIV immunology and vaccine development. He leads an international translational clinical and basic science research effort to understand how some rare people who are infected with HIV, but have never been treated, can fight the virus with their immune system.
Dr. Walker is also an Adjunct Professor at the Nelson Mandela School of Medicine in Durban, South Africa. He is a co-founder of the KwaZulu-Natal Research Institute for TB and HIV (K-RITH, recently renamed the Africa Health Research Institute, AHRI), an initiative initially funded by HHMI to build a state-of-the-art TB/HIV research facility at the heart of these dual epidemics in South Africa.
Dr. Walker is also a member of the American Academy of Arts and Sciences, American Society for Clinical Investigation (ASCI), the American Association of Physicians (AAP), and the National Academy of Medicine. He received his M.D. from Case Western Reserve University and his B.A. in Chemistry from the University of Colorado, and has been on the Harvard faculty since 1980.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Walker, B. (2020, April 14). Elite controllers of HIV: from discovery to future therapies [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/MXJT2430.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose
Audio Interview
Elite controllers of HIV: from discovery to future therapies
Published on April 14, 2020
31 min
A selection of talks on Microbiology
Transcript
Please wait while the transcript is being prepared...